Growth of U.S. Anti-snoring Devices Market Driven by Sleep Health Awareness

The U.S. market for anti-snoring devices is experiencing significant growth, fueled by increasing awareness of sleep health, a higher prevalence of sleep apnea, and a preference for non-invasive treatment options. Devices like mandibular advancement devices, tongue stabilizing devices, and nasal devices are gaining popularity due to their convenience for treating snoring and related sleep breathing disorders. Technological advancements have improved user adherence and ease of use.

According to SNS Insider, the U.S. Anti-snoring Devices Market was valued at USD 0.30 billion in 2025 and is projected to reach USD 0.69 billion by 2035, growing at a compound annual growth rate (CAGR) of 8.74% from 2026 to 2035. Globally, the market is expected to increase from USD 1.08 billion in 2025 to USD 2.57 billion by 2035, with a CAGR of 9.06%. Key factors driving this growth include rising awareness of sleep apnea, obesity, an aging population, and a shift toward home-based, non-invasive treatments.

North America leads the anti-snoring market with a share of 38%, attributed to high awareness of sleep disorders, advanced healthcare infrastructure, and widespread use of oral and nasal devices. The shift toward convenient solutions for snoring and sleep apnea is enhancing the sector's prominence. A rise in obstructive sleep apnea cases, alongside readily available prescription and over-the-counter solutions, bolsters this market position.

Mandibular Advancement Devices (MADs) hold approximately 42.5% of the market share due to their effectiveness in keeping the airways open during sleep. The demand for tongue stabilizing devices is increasing, appealing to consumers desiring non-invasive solutions, particularly those unable to use MADs. The thermoplastic material segment represents about 38.9% of the market due to its low cost and customization potential, while silicone is noted as the fastest-growing material for its biocompatibility and patient-friendly properties.

Specialty sleep clinics account for around 36.7% of the distribution channel, offering expert fitting and treatment for snoring and mild obstructive sleep apnea. Online retail is growing rapidly, driven by the convenience and privacy it offers, while homecare settings represent about 41.3% of the end-user segment as consumers increasingly favor DIY solutions. Sleep laboratories are emerging as the fastest-growing end-user segment.

Key companies in the U.S. anti-snoring device market include ResMed Inc., a leader in sleep and respiratory care products. ResMed's innovations, such as the AirFit N20i nasal mask with Snore Response Technology, reflect a commitment to enhancing treatment efficacy. Koninklijke Philips N.V. offers a diverse range of sleep and respiratory solutions, recently launching the SmartSleep Snoring Relief Band 2.0. Fisher & Paykel Healthcare Limited focuses on providing innovative respiratory therapies and recently entered the consumer market with its FDA-registered F&P Nasal Strips.

Looking ahead, the U.S. Anti-snoring Devices Market is expected to grow steadily until 2035, driven by heightened awareness of sleep-related issues, increasing cases of sleep apnea, the popularity of non-invasive home treatments, and online availability. Future developments will likely concentrate on customizable oral devices, smart technologies, and integrated sleep management solutions, with companies that combine advanced technology and e-commerce capabilities poised for success.